Diversity Action Plans in Clinical Trials

被引：0
作者：
Metcalfe, Rebecca K. [1 ]
Park, Jay J. H. [2 ]
机构：
[1] Univ British Columbia, Ctr Adv Hlth Outcomes, Vancouver, BC, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 2C 1280 Main St, Hamilton, ON L8S 4L8, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 332卷 / 21期
关键词：
D O I：
10.1001/jama.2024.16009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This Viewpoint discusses the US Food and Drug Administration's upcoming mandate on diversity actions plans for trial sponsors and the importance of developing accountability mechanisms to monitor those plans.
引用
收藏
页码：1785 / 1786
页数：2
相关论文
共 50 条
  • [21] Enhancing Diversity and Inclusion in Clinical Trials
    Corneli, Amy
    Hanlen-Rosado, Emily
    McKenna, Kevin
    Araojo, Richardae
    Corbett, Dawn
    Vasisht, Kaveeta
    Siddiqi, Bernadette
    Johnson, Tesheia
    Clark, Luther T.
    Calvert, Sara B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) : 489 - 499
  • [22] Diversity, Equity, and Inclusion in Clinical Trials
    Keegan, Grace
    Crown, Angelena
    Joseph, Kathie-Ann
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (01) : 221 - 232
  • [23] Ensuring diversity in clinical trials: The role of clinical pharmacology
    Masters, Joanna C.
    Cook, Jack A.
    Anderson, Ginger
    Nucci, Gianluca
    Colzi, Anna
    Hellio, Marie-Pierre
    Corrigan, Brian
    [J]. CONTEMPORARY CLINICAL TRIALS, 2022, 118
  • [24] Diversity in Clinical Pharmacology: A Call to Action
    Brown, Karen
    Etrouth, Shravani
    Jayachandran, Priya
    Moore, Jason
    Oni-Orisan, Akinyemi
    Vasist, Lakshmi
    Zheng, Songmao
    Zhou, Zhu
    Dresser, Mark
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) : 483 - 485
  • [25] Development of guidance for statistical analysis plans (SAPs) for clinical trials
    Ashma Krishan
    Deborah Stocken
    Steff Lewis
    Ed Juszczak
    Caroline Dore
    Paula Williamson
    Doug Altman
    Alan Montgomery
    Mike Clarke
    Carrol Gamble
    [J]. Trials, 16
  • [26] Development of guidance for statistical analysis plans (SAPs) for clinical trials
    Krishan, Ashma
    Stocken, Deborah
    Lewis, Steff
    Juszczak, Ed
    Dore, Caroline
    Williamson, Paula
    Altman, Doug
    Montgomery, Alan
    Clarke, Mike
    Gamble, Carrol
    [J]. TRIALS, 2015, 16
  • [27] Increasing diversity and inclusion in nephrology clinical trials
    Young, Bessie A.
    Rosas, Sylvia E.
    [J]. NATURE REVIEWS NEPHROLOGY, 2023, 19 (10) : 627 - 628
  • [28] Diversity and transparency in gynecologic oncology clinical trials
    de Oca, Mary Katherine Montes
    Howell, Elizabeth P.
    Spinosa, Daniel
    Knochenhauer, Hope
    Peipert, Benjamin J.
    Severson, Eric
    Ramkissoon, Shakti
    Akinyemiju, Tomi F.
    Previs, Rebecca A.
    [J]. CANCER CAUSES & CONTROL, 2023, 34 (02) : 133 - 140
  • [29] Increasing diversity and inclusion in nephrology clinical trials
    Bessie A. Young
    Sylvia E. Rosas
    [J]. Nature Reviews Nephrology, 2023, 19 : 627 - 628
  • [30] New Federal Incentives for Diversity in Clinical Trials
    Hwang, Thomas J.
    Brawley, Otis W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15) : 1347 - 1349
12345